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Sequence database search engines are bioinformatics algorithms that identify peptides from 
tandem mass spectra using a reference protein sequence database. Two decades of 
development, notably driven by advances in mass spectrometry, have provided scientists with 
more than thirty published search engines, each with its own properties. In this review, we 
present the common paradigm behind the different implementations, and its limitations for 
modern mass spectrometry datasets. We also detail how the search engines attempt to alleviate 
these limitations, and provide an overview of the different software frameworks available to the 
researcher. Finally, we highlight alternative approaches for the identification of proteomic mass 








Mass spectrometry has become the technique of choice for proteomics as part of the 
large scale analysis of proteins in complex samples (Aebersold & Mann, 2003; Aebersold et al., 
2013). The direct measurement of intact proteins, so-called top-down proteomics, remains 
analytically challenging, impairing its application to complex mixtures (Kelleher, 2004). As 
illustrated in Figure 1, high throughput, shotgun proteomics approaches, also referred to as 
bottom-up proteomics, therefore digest proteins into peptides after reduction of disulfide 
bonds. The peptides are subsequently separated, generally by liquid chromatography (LC), and 
are then brought into the mass spectrometer source for ionization. Two ionization techniques 
are principally used in proteomics: electrospray ionization (Fenn et al., 1989) and matrix 
assisted laser desorption ionization (MALDI) (Karas et al., 1985; Tanaka et al., 1988; Soltwisch 
et al., 2009).  
Once ionized, the peptides are subjected to tandem mass spectrometry, in which the 
mass over charge ratios (m/z) of the peptides entering the mass spectrometer are first scanned, 
yielding so-called MS or MS1 spectra.  Selected peaks (typically the ones with the highest signal) 
are then isolated and fragmented in the next step, and the m/z of the obtained fragment ions is 
measured and reported in MS/MS or MS2 spectra. In addition to the fragmentation of a specific 
precursor peptide m/z, an approach called data dependent acquisition (DDA) (Mann et al., 
2001), one can also fragment a larger subset, or even all, of the eluting peptides in an approach 
called data independent acquisition (DIA) (Doerr, 2015; Kuharev et al., 2015). In the latter, the 
MS1 scan is not necessarily acquired (Gillet et al., 2012). Three fragmentation methods are 
widely used in proteomics to generate MS2 spectra,: (1) collision induced dissociation (CID) 
(Wells & McLuckey, 2005), (2) higher-energy collision induced dissociation (HCD) (Olsen et al., 
2007), and (3) electron transfer dissociation (ETD) (Syka et al., 2004), each providing distinct 
types of fragment ions. 
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As illustrated in Figure 1, the experimental data obtained from shotgun proteomic 
experiments thus mainly consist of the acquired MS1 and MS2 spectra. With the advent of high 
acquisition rate instruments, proteomics datasets have reached sizes ranging from thousands to 
millions of spectra, rendering their manual interpretation impossible. As a result, the 
interpretation heavily relies on the use of bioinformatics.  Three main strategies have been 
established for the identification of peptide-derived tandem mass spectra (McHugh & Arthur, 
2008): (1) sequence database searching, where the spectra are searched against a database of 
reference protein (or peptide) sequences, (2) spectrum sequencing, where amino acid 
sequences are directly inferred from the spectra, and (3) spectral library searching, where the 
spectra are searched against a library of spectra from known compounds.  
This review describes the principles of the database searching paradigm. After first 
presenting the main principles and introducing the various software implementations, the so-
called search engines, we detail possible pitfalls of database searching, and provide solutions 
that alleviate these where available. Finally, we introduce some of the advanced operating 
modes for improved sample characterization. 
I. A brief history of database search engines 
 
Figure 2 illustrates the concept of database searching, the matching of experimentally 
obtained MS2 spectra against a sequence database. The MS2 spectra to search first undergo 
preprocessing, which for most search engines consists in filtering out low intensity peaks to 
retain only the most intense peaks. The sequence database against which the spectra will be 
matched is also processed, by in silico digestion and fragmentation of the sequences. This 
mimics the experimental enzymatic cleavage and fragmentation of sample proteins, and 
provides theoretical MS2 spectra that can then be compared to the experimental MS2 spectra. A 
set of search parameters provided by the user tunes the specifics of this comparison. Finally, the 
quality of each comparison is evaluated using algorithm-specific scores. The result is a list of 
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peptide candidates for each spectrum, so-called peptide -spectrum matches (PSMs), along with 
their respective score.  
A standard format, called mzIdentML (Jones et al., 2012), has been developed to 
encapsulate and exchange peptide and protein identification results from search engines. The 
mzIdentML format can be directly exported by many of the search engines, and converters are 
also available (http://www.psidev.info/tools-implementing-mzidentml). 
Database searching emerged as a fast and reliable alternative to spectrum sequencing, 
and was pioneered by the SEQUEST algorithm (Eng et al., 1994). Subsequently, the commercial 
alternative Mascot (Perkins et al., 1999), was quickly adopted by the community for its server-
based infrastructure, and the simplicity of interpretation of its scores. Numerous search engines 
have since become available to the scientific community, including multiple free and open-
source alternatives. Table 1 lists all search engines (to the best of our knowledge at the time of 
writing) ordered by date of publication or availability. This table shows how the number of 
search algorithms has steadily increased since the first publication of SEQUEST, consistent with 
the growing need for better and faster algorithms that are capable of handling ever larger 
datasets. In addition, the total number of citations (from 1994 to 2016) according to Thomson 
Reuters™ Web of Science™ is provided as a rough indicator of community adoption.  
The number of citations per year for the most common algorithms, based on the original 
publication, is also displayed as a timeline in Figure 3. Despite the relative inaccuracy of this 
usage metric, it appears that search engine usage has been dominated by the original search 
engines, SEQUEST and Mascot, followed closely by the early open-source alternatives OMSSA 
(Geer et al., 2004) and X! Tandem (Fenyo & Beavis, 2003). Interestingly, the total number of 
search engine citations seems to have stagnated in the past five years. The dramatic increase in 
the share of Andromeda (Cox et al., 2011) as part of MaxQuant (Cox & Mann, 2008) shows the 
importance of search engine integration in global data interpretation pipelines. Finally, the 
increasing prevalence of other algorithms (a category that includes recent engines such as 
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MS Amanda (Dorfer et al., 2014) and MS-GF+ (Kim & Pevzner, 2014)) shows the interest of the 
community for more innovative approaches. For further details on the citations statistics please 
refer to the supplementary material. 
II. Practical use of a search engine 
 
The input for a search consists of peak lists containing the spectra to search, a sequence 
database, and the search settings used to tailor the search to the experimental setup. 
A. Peak lists 
 
The raw mass spectrometer output contains all data acquired by the mass spectrometer 
in a vendor-proprietary format (Martens et al., 2005). Before these data can be analyzed by 
external software, the output has to be converted into an open and preferably standardized 
format. The reference format for mass spectrometry files is mzML (Martens et al., 2011). 
However, due to the complexity and size of mzML files, many search engines operate on simpler 
formats that contain only the MS2 peak lists, along with the precursor ion m/z, intensity and 
charge. The most common formats are dta, pkl, ms2, and mgf as reviewed in (Deutsch, 2012). 
Note that file format conversion can be conducted easily by ProteoWizard (Chambers et al., 
2012), and also that some search engines are able to read the vendor formats directly, either 
through use of the vendor application programming interfaces (APIs) or by incorporating 
ProteoWizard as part of their software package.  
The recorded data often include peaks that are not derived from peptides, and these can 
impair the identification efficiency of a search (Du et al., 2008). To address this issue the raw 
spectra can be submitted to specialized algorithms that improve spectrum quality and that 
reduce the prevalence of non-peptide derived spectra/peaks (Ning & Leong, 2007; Barbarini & 
Magni, 2010; Sheng et al., 2015). As detailed in (Renard et al., 2009), this preprocessing can be 
divided into three categories: (1) spectral quality scoring based on spectrum features and/or 
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clusters; (2) precursor pre-processing, which can improve precursor charge and isotope 
inference, as well as mass accuracy (Hsieh et al., 2010); and (3) MS2 spectrum processing which 
includes the merging of spectra, baseline reduction, noise filtering, and deisotoping. All of these 
steps can for instance be carried out in the OpenMS open-source proteomic software 
framework (Sturm et al., 2008). Spectrum processing options were also recently implemented 
in ProteoWizard as part of the raw files conversion (French et al., 2015). However, advanced 
preprocessing has become less relevant with the advent of high-resolution mass spectrometers, 
and of instruments equipped with advanced signal processing units that provide data that is 
directly interpretable by search engines. 
Most search engines expect spectra in the form of peak lists, where a peak is 
represented as an (m/z, intensity) pair. It is thus important to verify that the spectrum files 
have been output in centroid mode (Deutsch, 2012). If the MS2 peaks take the form of the 
original, bell-shaped detector trace curve (referred to as profile mode data), a peak-picker 
should be applied, for example via OpenMS (Lange et al., 2006) or ProteoWizard.  
B. Alternative data sources 
 
In a global effort for scientific transparency, an increasing number of researchers now 
share the experimental data that support their findings. Vast amounts of proteomics data are 
thus available to the community, and can, for example, be used to provide preliminary results 
while setting up an experiment (Barsnes & Martens, 2013). However, in order to fully exploit 
such data, it can be useful to update the database, or to use different algorithms or settings. In 
this way, the original data can be reprocessed, and possibly even repurposed (Vaudel et al., 
2015). Spectra from online repositories can thus be downloaded and reprocessed as if acquired 
locally. Numerous public repositories contain data for such reanalysis (Fenyo et al., 2010; Perez-
Riverol et al., 2014), including the PRoteome IDEntifications database (PRIDE) (Martens et al., 
2005; Vizcaino et al., 2016), the Global Proteome Machine Database (GPMDB)(Craig et al., 
2004), MaxQB (Schaab et al., 2012), Massive (http://massive.ucsd.edu), and PeptideAtlas 
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(Desiere et al., 2006). PRIDE data, for example, can be reprocessed seamlessly using multiple 
search engines via PeptideShaker (Vaudel et al., 2015) in combination with SearchGUI (Vaudel 
et al., 2011). 
C. Protein sequence databases 
 
As illustrated in Figure 2, search engines rely on a database of reference sequences for 
the identification of peptides. Sequence databases can be obtained from public resources such 
as the UniProt knowledgebase (UniProt, 2015), The National Center for Biotechnology 
Information (NCBI) Reference Sequence (RefSeq) Database (Pruitt et al., 2005), or the DNA Data 
Bank of Japan (DDBJ) (Mashima et al., 2016).  
UniProt is the result of an effort to centralize the protein sequences in complete 
proteomes, along with relevant knowledge about these proteins as extracted from the available 
literature. As such, it serves a standardized hub for protein sequences and associated 
information. It is divided into two distinct subsets: (1) UniProt-KB/Swiss-Prot, which contains 
manually curated and annotated proteins with an evidence ranking based on literature review; 
and (2) UniProt/TrEMBL, which contains non-reviewed, automatically inferred sequences.  
The NCBI reference database provides a non-redundant collection of genomic, 
transcriptomic, and proteomic sequences, and DDBJ is an online repository that contains both 
human genotype and phenotype data. Alternatively, specialized databases can be found for 
specific species, diseases, or sub-proteomes (Hong et al., 2008; Reddy et al., 2009; Lamesch et 
al., 2012; McQuilton et al., 2012; Howe et al., 2013; Harris et al., 2014; Gaudet et al., 2015; Urban 
et al., 2015).  
The choice of the sequence database to use has a strong impact on the results of the 
search. Indeed, it is important to note that it is impossible for a search engine to identify 
peptides from proteins that are not present in the selected database. The search database 
should thus cover the proteins that are likely to be present in the sample as comprehensively as 
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possible. If not all proteins in the sample are represented in the database, the spectra obtained 
from such unexpected proteins can be matched incorrectly to other proteins in the database, 
which results in false positive identifications (Foster, 2011; Knudsen & Chalkley, 2011). This is 
notably the case for common contaminants, e.g. human keratin proteins in non-human samples, 
which can lead to incorrect biological conclusions if misinterpreted (Bern et al., 2009; 
Ghesquiere et al., 2011). Known contaminants should therefore be included in the database, 
alongside the protein sequences of interest. A useful list of common contaminants can be found 
in the common Repository of Adventitious Proteins (cRAP) (www.thegpm.org/crap).  
It is important to keep in mind that very large sequence databases also affect the search 
sensitivity, as further discussed below. It is thus recommended to tailor the database to the 
species under study when possible. However, complete protein sequences are not available for 
all samples. In such cases, genomic or transcriptomic data can instead be used to infer a suitable 
search database (Dove, 1999; Nesvizhskii, 2014; Menschaert & Fenyo, 2015). Closely related 
species can also be used as a substitute database, or one could be derived from elements of 
sequences that are conserved between multiple species (Penel et al., 2009). 
Note that protein sequence databases are regularly updated; for instance, an updated 
version of UniProtKB is released monthly. It is always recommended to use the latest available 
database version, and to use the same version throughout a project in order to avoid biases 
when comparing samples. The database version should be documented in-house and, for the 
sake of reproducibility, in scientific publications.  
Finally, it is important to highlight that shotgun proteomics identifies peptides and not 
proteins. The proteins are only inferred from the peptide evidence, as will be further discussed 
below. 




The search space of a proteomics database search engine is defined as the collection of 
all possible peptide and fragment ions that need to be taken into account when a spectrum is 
searched. The number of possible peptides is the number of peptides that can be matched to a 
precursor m/z in the experimental data. It is influenced by the tolerance used to search the data, 
and therefore the instrument resolution, but also by all search parameters that can influence the 
number of possible peptide m/z matching measured precursor m/z. For example, adding a 
variable modification increases the concentration of possible m/z and therefore the chances to 
match a precursor m/z.   
Additionally, when a modified peptide matches a precursor mass, all possible 
localization combinations have to be tested and scored. It should also be noted that a substantial 
fraction of the spectra that end up as unidentified may arise from modified peptides (Chick et 
al., 2015; Bogdanow et al., 2016).  
To illustrate this effect, we used the example dataset of the CompOmics Proteomics 
Bioinformatics tutorials, a one hour gradient measurement of a HeLa trypsin digest on a Q 
Exactive, see (Vaudel et al., 2014) for details, and increased the search space in 14 different 
ways: (1) Isoforms, the isoforms of the canonical sequences were included in the database; (2) 
Trembl, UniProt/TrEMBL sequences were included in the database, (3) Vertebrates, a non-
species-specific database was used including all vertebrates canonical sequences from UniProt; 
(4) 4 mc, up to four missed cleavages were allowed; (5) Semispecific, semi-specific cleavage was 
allowed; (6) Variable Cmm, cysteine carbamidomethylation was considered as variable; (7) 
Phosphorylation, variable phosphorylation of S, T, and Y was included; (8) ABY, a-ions were 
included in the fragmentation of peptides; (9) ABCXYZ, all fragment ions were considered; (10) 
MS2 0.5 Da, the MS2 tolerance was changed to 0.5 Da; (11) MS1&2 0.5 Da, both MS1 and MS2 
tolerances were changed to 0.5 Da; (12) -4 to +4 Da, an isotopic shift of -4 to +4 Da was allowed 
for the precursors; (13) 1 to 4, peptides of charge 1 to 4 were included in the search; and (14) 1 
to 6, peptides of charge 1 to 6 were included in the search. Importantly, the minimal peptide 
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m/z considered was set to 500 m/z, and up to five modification sites were tested per peptide. 
For more details on the generation of these data, see 
mvaudel.github.io/onyase/review_figure/review_figure.html. 
Figure 4A shows the density of the number of peptides matching per precursor in the 
different search space enlargement cases sorted from lowest to highest median. As expected, 
the ms2 settings, fragment ions considered and tolerance do not alter the number of peptides 
per precursor distribution. Similarly, the inclusion of charge 1 peptides and isoforms, do not 
substantially alter the number of peptides per precursor. The first increase is observed when 
including higher charges, higher numbers of missed cleavages, variable cysteine 
carbamidomethylation, and TrEMBL sequences. Including larger isotope tolerance clearly 
increases the number of peptides considered.  
Similarly, adding phosphorylation as variable modification increases the median 
number of peptides per precursor by almost one order of magnitude. As visible from the density 
and inter-quartile distance, the phosphorylation site combinations increase the span of the 
distribution above all other settings, and without limitation on the number of sites considered 
the size of the search space can become challenging to manage. The semi-specific, non-species-
specific, and relaxed MS1 tolerance all increased the median number of peptides per precursor 
by over an order of magnitude. 
A direct consequence of a large search space is longer search times due to the number of 
possibilities to evaluate. Figure 4B shows the number of peptides to evaluate in every search 
space enlargement condition listed above. As expected, the total number of peptides evaluated 
follows the increase in median number of peptides per precursor.  With the notable exception of 
datasets searched with a low MS2 resolution, most peptides will however be rapidly discarded 
by the search engines because no fragment ion could be matched, as indicated by a hyperscore 
of 0 (Fenyo & Beavis, 2003).   
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Another direct consequence is the increased probability to match a spectrum incorrectly 
with a high score, and thus either a higher prevalence of false identifications, or a lower 
identification rate (Colaert et al., 2011; Muth et al., 2015). This is illustrated Figure 4C with the 
distributions of the scores of decoy matches, that are by design incorrect. One can clearly see an 
increase of the score attributed to these false hits as the search space increases, the search space 
enlargements via high mass tolerance having the most prominent effect.  
The presence of false positive matches with high scores makes it more difficult for 
search engines to distinguish the true hits from the others. Consequently, after estimation of E-
values from the hyperscore distributions, one can observe a drop in the number of identified 
PSMs at a given false discovery rate (FDR). To maximize the identification rate, the search space 
is therefore tailored to best represent the proteins present in the sample without bias using the 
search parameters. Table 2 lists the standard search parameters encountered in most search 
engines. 
The first search space confinement is achieved by adaptation to the sample under study, 
mainly by limitation of the sequence database to the sample content and thus only use 
sequences from a single species when possible (Yen et al., 2006; Borges et al., 2013; Muth et al., 
2013). Because the inclusion of all known protein isoforms as separate entries in the sequence 
database increases the search space, curated consensus sequences that present only one protein 
sequence per gene are often used. As already mentioned, the presence of potential protein 
modifications also greatly influences the search space. Protein modifications can be categorized 
into three groups: (1) in vivo modifications that carry biological or functional information, e.g. 
phosphorylation; (2) in vitro artefactual modifications that occur spontaneously in sample 
handling, e.g. methionine oxidation or the formation of amino-terminal pyroglutamate; and (3) 
in vitro intended modifications that are part of the sample preparation protocol, e.g. isobaric or 
other isotopically labeled tags.  
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Proteins that carry specific biological or functional modifications are often present at 
substoichiometric abundances and are therefore rarely detectable without enrichment (Nielsen 
et al., 2006; Millioni et al., 2011; Loroch et al., 2013; Solari et al., 2015). In order to avoid 
unnecessary enlargement of the search space, it is therefore recommended to refrain from the 
inclusion of protein modifications that fall below the limit of detection of the experimental 
setup. Artefactual or intended modifications have a much higher prevalence and therefore need 
to be accounted for in the search. However, many of the intended modifications will occur with 
a very high efficiency, typically >95%. All possible target residues can then be considered as 
modified. Such fixed, or static, modifications do not increase the search space as these simply 
replace the affected residue by the corresponding modified residue and are thus systematically 
included at all possible sites. This in contrast to variable, or dynamic, modifications, where both 
the modified and unmodified version of each affected residue has to be considered, which 
increases the search space exponentially. 
The search space is also most often adapted to the enzyme used to digest the proteins. 
This means that only peptides that abide by the enzyme cleavage rules are considered. To adapt 
to the efficiency of proteolytic cleavage, a certain number of allowed missed cleavages is 
allowed. Similarly, semi-specificity can be used to account for unanticipated cleavages. Allowed 
missed cleavages and semi-specificity both lead to a larger search space. 
Finally, the search space can be tailored to the performance of the instrument used. This 
is achieved by adaptation of the m/z tolerances. For most search engines, mass tolerances are 
set at both the precursor and fragment ion levels, and any theoretical peptide and fragment ions 
that fall outside of these tolerance ranges are excluded. Hence, less restrictive mass tolerances 
induce a large search space, while stricter tolerances reduce the search space. Search engines 
also allow the search space to be tailored to the fragmentation method used. The simplest 
setting includes the selection of the amino-terminal and carboxy-terminal fragment ions to 
consider (Roepstorff & Fohlman, 1984; Johnson et al., 1987). More advanced parameters 
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include the isotope range considered, the selection of neutral losses, or the use of expert 
fragmentation models (Skilling et al., 2004; Paizs & Suhai, 2005; Klammer et al., 2008; 
Neuhauser et al., 2012). The search space can also be tailored to the possible peptide charges 
expected from the applied ionization method. MALDI ionization yields singly charged ions, 
while higher charges (two to four) are typically considered for electrospray ionization.  
Note that many modern search engines support the selection of predefined settings, for 
example for high or low resolution instruments, or for different fragmentation models. This 
allows for a simpler setup of the search. Some settings can also be optimized by the search 
engines themselves, for example through the use of machine learning approaches (Barla et al., 
2008; Yang et al., 2012). The optimization of the search space is a complex multi-variable 
optimization procedure, and one can easily be overwhelmed by the number of settings available 
for each search engine. It is therefore recommended to start from a set of standard settings and 
then study the influence of a change in a specific setting to best model the sample, protocol and 
acquisition (Vaudel et al., 2011; Muth et al., 2015). While optimal values can vary between 
samples or instruments, the variability for a single setup is not substantial and usually does not 
require a complete optimization process for every experiment. Some quality control 
procedures, such as the verification of the efficiency of chemical labelling can however, be 
mandatory prior to publication, for a detailed example see (Aasebo et al., 2014). 
IV. Spectrum matching 
 
Different approaches have been established to match spectra to theoretical peptides. 
These can be categorized according to the approach used to infer the theoretical spectra 





Descriptive approaches are based on theoretical models of peptide fragmentation. A 
theoretical spectrum is generated for each peptide based on specified rules, and a similarity 
score is calculated between the theoretical and experimental spectrum. SEQUEST (Eng et al., 
1994) is one example of a search engine that uses this descriptive approach. The number of 
predicted fragments that are present in the experimental spectrum determines the quality of 
the match. Peptide fragmentation models can be very simple, with fixed, arbitrary intensity 
values for all b- and y-ions (Sadygov et al., 2004). 
B. Interpretative 
 
Interpretative approaches rely on the assumption that peptides can be identified from a 
series of fragment ions that are manually or automatically retrieved from the spectra. Each 
peptide candidate is partitioned into an amino acid sequence flanked by masses of unknown 
composition, and the algorithm then attempts to match this amino acid sequence and its masses 
to the search space. This approach was pioneered by PeptideSearch (Mann & Wilm, 1994), 
which showed that such extracted sequence “islands” could be matched to a database. Note also 
that through partial matching with sequence tags the search space can be significantly reduced, 
for example, as seen in open modification searching (Na et al., 2012). 
A more recent implementation of this strategy can be found in TagRecon (Dasari et al., 
2010) that can be used to identify mutations that occur in the masses that flank the extracted 
amino acid sequence, and in MS-GF+ (Kim & Pevzner, 2014) that is designed to cope with the 
emergence of novel mass spectrometry techniques and more accurate data. 
C. Stochastic 
In stochastic approaches, libraries of already identified spectra are used to model the 
theoretical spectrum of a given peptide. This model is thus specifically tailored to the 
instrument used and its performance. An example of such an algorithm is SCOPE (Bafna & 
Edwards, 2001). Stochastic models require large training datasets to determine the likelihoods 
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and features of tandem mass spectra. Typically, these models are devised using machine 
learning and are based on the intrinsic properties of existing data (Kelchtermans et al., 2014). 
The model is however vulnerable to fluctuations in mass spectrometer performance and 
experimental setup. 
V. Calculation of peptide to spectrum scores 
 
For all PSMs, a scoring algorithm is employed to provide a quality metric for the matches 
between a spectrum and its proposed progenitor peptides. This score is then used to rank the 
results and retain only the best peptide-to-spectrum matches (PSMs). This can be achieved by 
(A) correlation and ion scores, or (B) statistical and probabilistic approaches (Sadygov et al., 
2004). 
A. Correlation and ion scores 
 
This method was pioneered by SEQUEST (Eng et al., 1994), where scores are calculated 
in two stages: (1) a preliminary score, Sp, is calculated as the summed intensity of all peaks that 
match the predicted fragment ion masses; and (2) for the 500 top candidates, a cross-
correlation value of the experimental versus the theoretical spectra is calculated (the XCorr 
score), and normalized (the Cn score). Similarly, X! Tandem bases its scoring on the hyperscore, 
where the cross correlation is further multiplied with the factorial of the number of matched 
peaks. It is important to note that these correlation-based scores are deterministic, they will 
always be the same between a given peptide and spectrum. 
The main drawbacks of this approach are: (1) its dependence on the quality of the 
spectra, the peptide length, the considered modifications and charge states, (2) the difficulty to 
interpret the scores, and (3) the computational load of the cross correlation analysis - note 




B. Statistical and probabilistic approaches 
 
Most search engines estimate the significance of deterministic scores in the context of 
the search. For example, X! Tandem transforms the deterministic hyperscore into an E-value 
that will depend on the search space. SEQUEST uses a relative score that represents the 
difference between the Cn of the best and second best peptide candidates for a particular 
spectrum (the ΔCn score). Statistical and probabilistic approaches hence estimate the 
probability of a match to occur randomly in the search space. This approach, pioneered by 
Mascot (Perkins et al., 1999), has become very popular for its simplicity of interpretation. 
Mascot’s algorithm is however, kept a trade secret. Open search engines such as X! Tandem 
(Fenyo & Beavis, 2003) and OMSSA (Geer et al., 2004) were later released as open-source 
alternatives that follow a similar approach, with different distributions to model the population 
of matching scores. More recently, Andromeda (Cox et al., 2011) and MS Amanda (Dorfer et al., 
2014)  have become available as additional free alternatives, based on related probabilistic 
models that perform similar to Mascot. Andromeda can either be used as a standalone search 
engine or as a part of MaxQuant (Cox & Mann, 2008). 
In contrast to ion scores, probabilistic scores depend on the experiment and search 
space. When the search space grows the distribution of scores from random matches spans a 
wider range, as illustrated Figure 4C. The difference in score between the correct matches and 
the random identifications therefore decreases, making it harder to distinguish the correct 
identifications from the others. This loss of discrimination power yields a lower search 
sensitivity, and eventually a lower identification rate as illustrated Figure 4D. 
 




Advanced search strategies have been developed to circumvent the limitations of 
enlarged search spaces, and thus increase the identification coverage of proteomic workflows. 
In multi-stage search strategies, spectra are searched iteratively, where the result of one 
iteration is used to select seed peptides or proteins presumably present in the sample, and then 
only these are considered in the next iteration, as illustrated with the feedback loop to the 
protein list in Figure 2.  
X! Tandem employs a second search stage called refinement where the result of the first 
search is used to establish a set of high confidence proteins. The spectra are subsequently 
searched again using relaxed settings (semi-enzymatic cleavage, higher number of missed 
cleavages, additional modifications, etc.), but only against the set of proteins detected in the first 
iteration. As a result, the search engine quickly identifies more peptides for these proteins, 
circumventing search space enlargement issues. A similar procedure is called error-tolerant 
search in Mascot (Creasy & Cottrell, 2002) and iterative search in OMSSA. However, the arbitrary 
selection of confident proteins from one stage to the other, can introduce a bias in the scores of 
matches in multiple stage strategies, which ultimately impairs the reliability of downstream 
peptide-level false discovery rate estimation strategies (Everett et al., 2010; Bern & Kil, 2011). 
The results of multiple stage searches should thus be interpreted with care (Jeong et al., 2012).  
A similar strategy to reduce the search space is to iteratively filter out spectra and 
search the remaining non-identified spectra against another database (Noble, 2015). In such 
cascaded searches, the search space is gradually shifted, starting from background peptides to 
peptides of interest, which reduces the prevalence of random false positive matches (Kertesz-
Farkas et al., 2015). However, the lack of competition between hits induced when the database 
is tailored towards a given hypothesis is known to generate false positives matches of non-
random nature (Colaert et al., 2011). Here again, the possible underestimation of error rates 
should thus be kept in mind when the results are interpreted. 
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More than 100,000 peptides elute in a typical proteomic shotgun experiment (Michalski 
et al., 2011), consequently, two different peptides may be isolated, fragmented, and recorded 
simultaneously, which results in so-called chimeric spectra (Houel et al., 2010). Almost all 
search engines are however, designed to identify only a single peptide per spectrum. 
Consequently, only one peptide is identified, generally the one that corresponds to the dominant 
peaks in the fragmentation spectrum. (It should be noted however, that if the difference in 
precursor mass between the peptides included in the chimeric spectrum is larger than the 
allowed mass tolerance, than the precursor mass will be the primary determinant for 
identification.) To alleviate this problem, some search engines implement another advanced 
procedure that consists of a removal of the signal of the identified peptide from the spectrum, 
followed by a re-search of the remaining unidentified peaks for possible co-fragmented 
peptides. This method is notably implemented in Andromeda where it was reported to provide 
up to 10 % additional hits (Cox et al., 2011).  
Finally, error-tolerant searches can be used as a strategy to identify peptides outside of 
the search space, as additional degrees of freedom are allowed, e.g. mass differences induced by 
unexpected modifications, sequence variants, or non-enzymatic cleavage sites. This strategy is 
notably available in Mascot (Creasy & Cottrell, 2002) 
(www.matrixscience.com/help/error_tolerant_help.html). A similar approach is to search with 
very high tolerances and filter matches a posteriori (Beausoleil et al., 2006). Mass tolerant 
searches can be combined with clustering of PSMs to match peptides to a wide range of 
modifications and sequence variants (Chick et al., 2015). 
VII. Conclusion and overview 
 
Database searching has become the identification method of choice in proteomics. In a 
global attempt at enhancing the performance of searches, multiple implementations have been 
made available to researchers. Each of these offers different variations on the basic principles 
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presented in Figure 2. The increasing number of available search engines (Figure 3), highlights 
the highly dynamic development of this field of research. Additional resources have also become 
available for upstream and downstream processing of the data, and search engines have been 
integrated in software environments that allow the design of complex workflows, as for 
example in the Trans Proteomic Pipeline (TPP) (Deutsch et al., 2010), OpenMS (Sturm et al., 
2008), MaxQuant (Cox & Mann, 2008), and Pladipus (Verheggen et al., 2016). Among the 
downstream procedures, several are notable for an intricate link to the search engines: (1) error 
rate estimation, (2) multiple algorithm integration, and (3) protein inference.  
Error rate estimation is generally achieved by a false discovery rate (FDR) estimation, 
which provides an estimate of the share of incorrect matches retained. This is important 
because, as detailed above, search engines provide only a list of candidate peptides along with a 
score for each peptide. The researcher must somehow establish a certain score cut-off from 
these results to control the quality of the retained set, as reviewed in (Vaudel et al., 2012). Two 
main methods are available for this control of error rates: search engine score modeling (Keller 
et al., 2002) and the use of target/decoy databases (Elias & Gygi, 2007). A third approach, which 
relies on lower ranked hits has also been proposed recently (Gonnelli et al., 2015). For a 
detailed review on error rate estimation procedures in proteomic identification results, see 
(Nesvizhskii, 2010). 
In order to benefit from the complementarity of available search engines, methods for 
the integration of multiple search engines have been established, and these can provide a 
substantial gain in identification coverage (Yen et al., 2006; Searle et al., 2008; Yu et al., 2010; 
Shteynberg et al., 2013). In addition, search engines can also be combined with alternative 
identification approaches to overcome the drawbacks of using a sequence database. The first 
useful alternative is the use of spectral libraries, where newly acquired experimental spectra 
are matched to previously identified spectra (Craig et al., 2006; Bandeira et al., 2007; Lam et al., 
2007; Frank et al., 2011). The second alternative approach that can be combined with search 
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engines is de novo sequencing (Seidler et al., 2010; Allmer, 2011; Medzihradszky & Chalkley, 
2015). In de novo sequencing, the peptide amino acid sequence is partially or completely 
inferred from the spectrum. While computationally intensive, this method presents the 
advantage of being virtually unbiased toward sequence databases. The combination of these 
approaches can, for example, be achieved using IDPicker (Ma et al., 2009). 
As detailed in the introduction, shotgun proteomics only allows the identification of 
peptides. Before drawing conclusions at the protein level, the presence of a protein must 
therefore first be inferred from the identified peptides. This task is made complex by the 
presence of peptides shared between proteins (Nesvizhskii & Aebersold, 2005). Moreover, this 
problem propagates to the downstream tasks in a proteomic bioinformatics workflow, for 
instance protein identification error rate estimation, protein quantification, and post-
translational modification studies. The inference of proteins from peptides is particularly 
complicated in the case of multiple search engine workflows, due to the inconsistencies of 
peptide-to-protein association between algorithms, and for multiple samples or fractionated 
samples, where the protein inference step must take into account the complexity of the 
experimental design (Vaudel et al., 2013). 
Such newer and more complex search strategies, along with the growth in data set size, 
make it increasingly difficult to conduct a search within a reasonable time frame. This is 
particularly problematic in the case of proteogenomics studies (Nesvizhskii, 2014) and 
metaproteomics (Muth et al., 2013). Distributed computing can help overcoming some of these 
limitations, through the use of grid or cloud computing (Verheggen et al., 2014). This way, 
extensive processing power can be made available to the community at large, notably through 
the establishment of dedicated environments, like the Galaxy project (Giardine et al., 2005; 
Boekel et al., 2015). It is also possible to distribute tasks on a local cluster of computers, making 
it possible for most labs to carry out demanding searches even with limited informatics 
resources (Verheggen et al., 2016). Moreover, cloud-based systems that run on third-party 
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hardware over the internet, have also been devised (Halligan et al., 2009; Trudgian & Mirzaei, 
2012; Muth et al., 2013; Slagel et al., 2015). 
The increase in performance offered by these new database search setups has made it 
possible to conduct global proteome analyses and provide the first maps of the human 
proteome (Kim et al., 2014; Wilhelm et al., 2014). Such large scale investigations can in turn be 
combined with other omics results that together provide an unprecedented characterization of 
a biological system (Cabezas-Wallscheid et al., 2014; Robles et al., 2014; Hein et al., 2015). A 
promising multi-omics application is the growing field of proteogenomics, where genomics, 
transcriptomics, proteomics, and epigenomics are combined to provide a fine-grained analysis 
of the gene translational and transcriptional processes (Jaffe et al., 2004).  
Proteomic search engines play a key role in these approaches (Menschaert & Fenyo, 
2015), and the control of the search space size and prevalence of false positives, especially of a 
non-random nature, is vital for their success (Nesvizhskii, 2014). The availability of increasing 
amounts of data in ever-improving quality from public repositories  is a great advantage when 
searching for low abundant compounds , and also enables big data mining of all the globally 
acquired data in order to achieve unprecedented insights into biological systems (Vaudel et al., 
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Figure 1: In a typical shotgun proteomics workflow, proteins are extracted from biological 
samples, their tertiary and secondary structures are reduced to a linear form, and undergo 
proteolytic digestion. The obtained peptide mixture is usually fractionated to reduce its 
complexity and analyzed by liquid chromatography coupled to tandem mass spectrometry (LC-
MS/MS). The acquired data consist of two types of mass spectra: MS1 spectra that show the 
intensity versus m/z of the different ionized analytes at a given LC retention time, and MS2 
spectra that show the intensity versus m/z of the fragmentation products of analytes called 
precursors that are isolated at a given retention time and mass range prior to dissociation, e.g. 







Figure 2: Database search engines attempt to match experimentally obtained MS2 spectra to 
peptides derived from sequence databases. Their function can be summarized in four steps: (1) 
spectra are filtered to reduce the number of peaks to process, (2) theoretical spectra are derived 
from the database sequence, (3) theoretical and experimental spectra are compared and their 
match is scored, and (4) peptide-spectrum matches (PSMs) are exported for post-processing. 
The different steps are controlled by search settings, meant to tune the search engine to the 
experimental conditions. Additionally, advanced search configurations allow the identification 





Figure 3: The yearly number of citations (from 1994 - 2016) for the search engines listed in 
Table 1 according to Thomson Reuters™ Web of Science™, counting the original publication 
only. The eight most cited search engines are listed individually, while the rest are grouped in 
the Other category. The number of citations can be used as an indicator of the prevalence of a 
given search engine in the literature, albeit with caution (see main text and the supplementary 







Figure 4: A) The density of the number of possible peptides per precursor is plotted as violin 
plot for every search space enlargement parameter (see main text) after logarithm base 10 
transformation. In each case, a large dash represents the median and two smaller dashes 
represent the upper and lower quartiles. The densities are colored according to the type of 
parameter changed, and ordered by increasing median. B) The number of peptides considered 
during the search is plotted for every setting of Table 1 in the same order and coloring as in 4A. 
The peptides with a hyperscore > 0 are outlined in black. C) The density of the scores of decoy 
hits is plotted as in 4A using the same order. D) The number of target PSMs in every condition is 
plotted at 1%, 5%, and 10% False Discovery Rate (FDR) in green, orange, and red, respectively. 






Name Year Website Publication #Citations 
SEQUEST 1994 fields.scripps.edu/sequest (Eng et al., 1994)  3844 




(Zhang et al., 2002)  159 




(Sadygov & Yates, 2003)  147 
OLAV 2003 - (Colinge et al., 2003)  220 
VEMS 2003 portugene.com/vems.html (Matthiesen et al., 2003) 17 
Phenyx 2004 genebio.com/products/phenyx/index.html - - 
OMSSA 2004 ftp.ncbi.nlm.nih.gov/pub/lewisg/omssa (Geer et al., 2004)  821 
X! Tandem 2004 thegpm.org/TANDEM (Craig & Beavis, 2004) 1228 
ProbIDTree 2005 - (Zhang et al., 2005)  53 
DBDigger 2005 - (Tabb et al., 2005)  43 
pFind 2005 pfind.ict.ac.cn (Li et al., 2005)  57 
InSpect 2005 proteomics.ucsd.edu/Software/Inspect (Tanner et al., 2005)  383 
IdentityE 2007 - - - 








(Tabb et al., 2007)  253 




(Alves et al., 2008)  10 
Zcore 2009 - (Sadygov et al., 2009)  25 




(Faherty & Gerber, 2010)  16 
MS-Tag and 
Batch-Tag 
2010 prospector2.ucsf.edu/prospector (Chu et al., 2010)  35 
Tide 2011 noble.gs.washington.edu/proj/tide (Diament & Noble, 2011)  34 
Andromeda 2011 maxquant.org (Cox et al., 2011)  1009 
SpectrumMill 2011 proteomics.broadinstitute.org - - 
MassWiz 2011 masswiz.igib.res.in (Yadav et al., 2011)  19 
SQID 2011 - (Li et al., 2011)  27 
PeaksDB 2011 bioinfor.com/peaks/features/peaksdb.html (Zhang et al., 2012)  3 
MSPolygraph 2011 compbio.eecs.wsu.edu 
(Kalyanaraman et al., 
2011) 
9 
Tempest 2012 - (Milloy et al., 2012)  9 
Byonic 2012 proteinmetrics.com (Bern et al., 2012)  0 
39 
 
Morpheus 2013 sourceforge.net/projects/morpheus-ms (Wenger & Coon, 2013)  33 
Comet 2013 comet-ms.sourceforge.net (Eng et al., 2013)  104 
ProLuCID 2013 fields.scripps.edu/prolucid - - 
MS-GF+ 2014 proteomics.ucsd.edu/software-tools/ms-gf (Kim & Pevzner, 2014)  71 
MS Amanda 2014 ms.imp.ac.at/?goto=msamanda (Dorfer et al., 2014)  40 
Greylag 2015 greylag.org - - 
 
Table 1: Search engines listed by year of publication or availability. When available, the search 
engine website is provided, along with the related original publication and its total number of 





Name Description Value 
Database 
A text file containing a list of amino acid 
sequences to search in the FASTA format. 
The sequences included should best cover the 
sequences present in the sample, but not contain 
a large proportion of additional sequences. 
Contaminants must be included. 
Modifications 
Mass modifications to be applied to the 
amino acids in the database. These can be 
fixed or variable, target single amino acids, 
amino acid patters, and specific locations on 
peptide or protein sequences. 
The modifications searched need to account for 
modifications introduced during sample 
processing, artefactual modifications, and 
biological modifications. 
Digestion 
The sequences in the database can be 
searched in their entirety, cleaved 
unspecifically, or cleaved using an enzyme. 
The digestion setting needs to best represent the 
method used to obtained peptides, if any. 
Enzyme 
The cleavage rule of the enzyme, e.g. “After 
K or R when not followed by P”. Some search 
engines support multiple enzyme digestion. 
If an enzyme was used to digest the proteins, the 
cleavage rule should best model what peptides 
can be expected from proteins. 
Specificity 
It is possible to search for fully specific 
peptides, with both termini abiding by the 
cleavage rule, as well as semi-specific 
peptides, where only one terminus abides by 
the cleavage rule. The semi-specificity can be 
two sided, or limited to the C- or N-terminus.  
This setting provides a degree of freedom in case 
the digestion was not complete, or if the proteins 
are not expected to be in full length in the 
sample. 
Missed Cleavages 
A certain number of missed cleavages can be 
allowed to account for partial digestion of 
peptides or the inaccuracy of cleavage rules. 
This setting is usually set to 2 for trypsin, but 
should be optimized to account for digestion 
efficiency. 
Fragment Ions 
The fragment ions to annotate in spectra 
need to be set to account for the 
fragmentation method used.  
Generally, b and y ions are used for CID and HCD 
fragmentation, c and z ions are used for ETD 
fragmentation. 
Precursor Tolerance 
The tolerance used to match a theoretic 
peptide m/z to a measured precursor m/z. 
This tolerance can be absolute or relative.  
The tolerance needs to be adapted to the 
resolution at which the MS1 spectra were 
measured. A relative tolerance in ppm is used for 
high resolution MS1 data. 
Fragment Tolerance 
The tolerance used to match a theoretic 
fragment m/z to a measured fragment ion 
m/z. As for the precursor, this tolerance can 
be absolute or relative. 
The tolerance needs to be adapted to the 
resolution at which the MS2 spectra were 
measured. A relative tolerance in ppm is used for 
high resolution MS2 data. 
Precursor Charge 
The charge of the peptide to search for can 
be set.  
The charge needs to be adapted to the charge 
targeted by the mass spectrometer for 
fragmentation, typically 1 for MALDI ionization, 2 
to 4 for electrospray ionization. 
Isotopes 
The isotopes to account for relative to the 
monoisotopic peak. 
Peptides with one 13C are usually included in the 
search to account for incorrect monoisotopic 
peak assignment by the mass spectrometer. This 
value needs to be optimized based on the 
monoisotopic peak selection settings. 
 
Table 2: The standard parameters enountered in most search engines. A description of each 
parameter is provided along with guidance on how to set and optimize the value for a given search.  
 
